Cutaneous Oncology News

Nicotinamide therapy was not effective in lowering the rates of keratinocyte cancers or actinic keratoses in immunosuppressed solid-organ transplant recipients, according to a phase 3 trial.

Due to the lack of clarity in literature, widespread implementation of consensus recommendations for actinic keratoses and cutaneous squamous cell carcinoma is needed, according to a study.

MIAMI BEACH, Fla. — The 31-gene expression profile test demonstrated accurate melanoma-specific survival predictions and may help guide clinicians in adjuvant therapy management, according to a poster presentation at South Beach Symposium.

MIAMI BEACH, Fla. — Artificial intelligence should be thoughtfully evaluated for the use of skin cancer detection, according to a presenter at South Beach Symposium.

Cutaneous immune-related adverse events are associated with increased survival rates among immune checkpoint inhibitor recipients, particularly in patients with melanoma, according to a study.

Dermatologists and dermatopathologists should increase the utilization of nail clipping histopathology to aid in the diagnosis of nail unit melanoma, according to a perspective published in the Journal of Cutaneous Pathology.

Functional surgery may be an attractive option in patients with nail unit melanoma who have a Breslow thickness less than 0.8 mm, according to a study.

The addition of all-trans retinoic acid to pembrolizumab conferred benefit to patients with metastatic melanoma, according to results of a phase 1b/phase 2 trial published in Clinical Cancer Research.

The cutaneous toxicities associated with cancer checkpoint inhibitors were varied depending on the malignancy and checkpoint inhibitor used, according to a study.

WAILEA, Hawaii — The treatment of actinic keratosis can be challenging. At the Maui Derm meeting, George M. Martin, MD, meeting founder and program director, and Ted Rosen, MD, gave an update on treatment options.